- NCIt
- C213198
Loading cancer entity…
Loading cancer entity…
Clinical trials
9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07040280 | Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma | recruiting | Phase 2 | 120 | ECOG-ACRIN Cancer Research GroupNETWORK | 1 | Sep 15, 2026 | clinicaltrials |
| NCT06246903 | INTER-PATHOLOGIST READER STUDY | unknown | — | 500 | Orlucent, IncINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05446155 | BioMEL- Diagnostic and Prognostic Factors in Melanoma.(BioMEL) | recruiting | — | 2,000 | Region SkaneOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT03725449 | Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma | completed | N/A | 116 | Rutgers, The State University of New Jersey |
Data updated 14 days agoSource updated Sep 15, 2026source: clinicaltrials
| 1 |
| Nov 14, 2022 |
| clinicaltrials |
| NCT04353050 | Atypical MOLes and Melanoma Early Detection Study (MoleMed)(MoleMed) | unknown | N/A | 350 | Russian Academy of Medical SciencesOTHER | 1 | Jun 14, 2022 | clinicaltrials |
| NCT00339222 | Family Study of Melanoma in Italy | completed | — | 1,708 | National Cancer Institute (NCI)NIH | 2 | Jul 1, 2020 | clinicaltrials |
| NCT03094273 | Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi | completed | — | 138 | NYU Langone HealthOTHER | 1 | May 8, 2019 | clinicaltrials |
| NCT00710489 | Potential Research Study Participant Registry | completed | — | 265 | University of California, DavisOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT03362138 | Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions(NNCD) | unknown | — | 80 | Assuta Hospital SystemsOTHER | 1 | Sep 13, 2018 | clinicaltrials |